Series B Pharmaceutical Companies

Arkuda Therapeutics is a pharmaceutical company.

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.

Technology-driven infusion therapy company

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Nuevocor operates as a preclinical-stage biotech company.

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders.

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Drug candidates with a unique mechanism of action, aiming to reduce inflammation and pain. Vipoglanstat to enter phase II for endometriosis.

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials.

Basecamp Research leverages their unprecedented knowledge of the natural world to create better medicines, better food and better products

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.